首页> 外文学位 >Part I. The synthesis and structure-activity relationship study of azo dye related HIV replication inhibitors. Part II. Plant isolation of signalling pathways inhibitors as anti-cancer agents.
【24h】

Part I. The synthesis and structure-activity relationship study of azo dye related HIV replication inhibitors. Part II. Plant isolation of signalling pathways inhibitors as anti-cancer agents.

机译:第一部分:偶氮染料相关的HIV复制抑制剂的合成及其构效关系研究。第二部分植物分离的信号通路抑制剂为抗癌剂。

获取原文
获取原文并翻译 | 示例

摘要

Since HIV-1 was identified as the causative agent of AIDS, many polyanionic compounds have been found possessing anti-HIV activity. Among them, several commercial dyes, such as Chicago Sky Blue, Even's Blue, Congo Red, and Direct Orange 15, attracted a lot of attention, because of their specificity and different mechanisms of actions from AZT. Quinobene, which was modeled after Chicago Sky Blue, surpassed this dye in activity. But two drawbacks prevented quinobene from further consideration in clinical evaluation: low bioavailability and highly intense color. In this part of my research, a series of compounds, structurally related to quinobene and Direct Orange 15, were prepared in an effort to improve these pharmacological properties, and to provide a structure-activity relationship (SAR). Several compounds of much lighter color showed potent activity in the NCl in vitro assay. Some interesting SARs have been observed, such as the observation that azo linkages could be replaced with other groups of similar size and configuration, such as amide, without loss of activity.; Intracellular signal transduction pathways play an important role in tumorigenesis, because two thirds of known proto-oncogenes act by coding for components of these pathways. Proteins encoded by these oncogenes, which are constitutively active analogs, under certain circumstances, lead to the cell's neoplastic transformation. Therefore, oncogene signal transduction is a logical target at which to direct a new anticancer drug development. In this research, specific components targeted included various growth factors (vasopressin, bradykinin, and platelet-derived growth factor), and enzymes (phosphoinositide specific phospholipase C, phosphatidylinositol-3-kinase, tyrosine protein kinase, and protein kinase C). A large number of plant extracts were assayed against these targets. Four plant extracts, Geranium carolinium, Polygonum pennsylvanicum, Daucus carota, and Rhododendron catawbinse, were found active. Bioassay-directed fractionation of these active extracts led to potent inhibitors. A pure compound from R. catawbinse, dendropanoxide, was identified for the first time as a PKC inhibitor. A herbicide, oryzalin, was accidentally found to be an excellent inhibitor against Ca{dollar}sp{lcub}2+{rcub}{dollar} signalling and several tumor cell lines. Several other active compounds were also isolated, but were not identified due to insufficient quantities.
机译:自从HIV-1被确定为AIDS的病因以来,已发现许多具有抗HIV活性的聚阴离子化合物。其中,由于其特异性和与AZT不同的作用机理,诸如芝加哥天蓝色,Even的蓝色,刚果红和Direct Orange 15等几种商业染料引起了很多关注。以芝加哥天蓝色为蓝本的喹啉烯在活性上超过了这种染料。但是有两个缺点使奎诺贝恩无法在临床评估中进一步考虑:生物利用度低和颜色强烈。在我的研究的这一部分中,制备了一系列与喹啉和直接橙15有关的化合物,以改善这些药理特性并提供构效关系(SAR)。几种较浅颜色的化合物在NCI体外测定中显示出有效的活性。已经观察到一些有趣的SAR,例如观察到偶氮键可以被类似大小和构型的其他基团取代,例如酰胺,而不会失去活性。细胞内信号转导途径在肿瘤发生中起重要作用,因为三分之二的已知原癌基因通过编码这些途径的成分起作用。这些致癌基因编码的蛋白质在某些情况下是组成性活性类似物,可导致细胞发生肿瘤转化。因此,癌基因信号转导是指导新的抗癌药物开发的逻辑目标。在这项研究中,靶向的特定成分包括各种生长因子(加压素,缓激肽和血小板衍生的生长因子)和酶(磷酸肌醇特异性磷脂酶C,磷脂酰肌醇-3-激酶,酪氨酸蛋白激酶和蛋白激酶C)。针对这些靶标分析了大量植物提取物。发现四种植物提取物有活性,天竺葵carolinium,何首乌,Daucus carota和杜鹃花catawbinse。这些活性提取物的生物测定指导分馏产生了有效的抑制剂。首次鉴定出来自卡托宾酶的一种纯净化合物,dendropanoxide,是一种PKC抑制剂。偶然发现一种除草剂米杂草素是抗Ca {dollar} sp {lcub} 2+ {rcub} {dollar}信号传导和几种肿瘤细胞系的优良抑制剂。还分离了其他几种活性化合物,但由于数量不足而未被鉴定。

著录项

  • 作者

    Lu, Hang.;

  • 作者单位

    Georgia Institute of Technology.;

  • 授予单位 Georgia Institute of Technology.;
  • 学科 Chemistry Biochemistry.; Chemistry Organic.; Chemistry Pharmaceutical.
  • 学位 Ph.D.
  • 年度 1994
  • 页码 172 p.
  • 总页数 172
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 生物化学;有机化学;药物化学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号